Search results
illumiPure Inc. Achieves IEC 62471 Exempt Certification, Setting New Standard in Lighting Technology
The Joplin Globe· 3 days agoHOUSTON, TX / ACCESSWIRE / April 29, 2024 / illumiPure, Inc., a leader in innovative LED solutions,...
Q1 2024 Openlane Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 hour agoIn addition to the volume opportunities, I believe we can accelerate growth by capitalizing on the opportunities that are enabled by our asset-light digital model. We continue ...
FuelCell Energy and Toyota Motor North America Celebrate Launch of World's First 'Tri-gen'...
FOX 4 Kansas City· 52 minutes agoFuelCell Energy's Tri-gen technology produces three products: renewable electricity, renewable hydrogen, and usable waterMarks...the world to be powered by onsite-generated ...
POET Technologies Target of Unusually High Options Trading (NASDAQ:POET)
ETF DAILY NEWS· 1 day agoPOET Technologies Inc. (NASDAQ:POET – Get Free Report) was the target of unusually large options trading on Tuesday. Traders acquired 3,204 call options on the stock. This ...
Top 20 Tech Companies in Silicon Valley
Insider Monkey via Yahoo Finance· 21 hours agoIn this piece, we will take a look at the top 20 technology companies in Silicon Valley. If you want to skip our coverage of the world’s technology hub...
Bio-E Introduces Pearly White Essence Drink, Enhancing Skin Brightness with Advanced Genetic ...
Digital Journal· 3 days agoAchieves IEC 62471 Exempt Certification, Setting New Standard in Lighting Technology More from Digital Journal Let’s waltz! Vienna ball season back in full swing ‘Avatar 2 ...
RMS Titanic, Inc. Announces July Dates for TITANIC 2024 Imaging and Research Expedition
WKBN 27 Youngstown· 3 days agoRMS Titanic, Inc., the salvor-in-possession of the RMS Titanic, today announced the dates for its 2024 Imaging and Research Expedition. The company also unveiled details about ...
PACCAR Inc (PCAR) Reports Strong Q1 2024 Earnings, Surpassing An
Guru Focus· 2 days agoPACCAR Inc (PCAR, Financial), a renowned global technology leader in the design, manufacture, and...
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the...
The Joplin Globe· 7 days agoTuHURA recently announced it has entered into a definitive agreement for an all-stock transaction with Kintara Therapeutics, Inc. ("Kintara") to form a company combining expertise ...
POET Announces CAD$10 Million Non-brokered Financing
Digital Journal· 3 days agoActual results could differ...
